Release Date: 30/11/10 13:41 Summary: Chairman's Address to AGM Price Sensitive: No Download Document 36.08KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%